Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

An Introduction to Drawdown Risk

Mutualfunds logo

SWHFX Schwab Health Care

  • Fund
  • SWHFX
  • Price as of: Jun 23, 2017
  • $25.37
  • + $0.04
  • + 0.16%
  • Category
  • Health & Biotech Equities

SWHFX - Profile

Vitals

  • YTD Return 17.2%
  • 3 Yr Annualized Return -0.5%
  • 5 Yr Annualized Return 6.2%
  • Net Assets $839 M
  • Holdings in Top 10 45.4%

52 WEEK LOW AND HIGH

$25.37
$21.19
$25.37

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 54.00%

TRADING FEES

  • Max Redemption Fee 2.00%

Min Investment

STANDARD (TAXABLE)

$100

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 17.2%
  • 3 Yr Annualized Total Return 11.0%
  • 5 Yr Annualized Total Return 30.7%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.82%
DIVIDENDS
  • Dividend Yield 0.2%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Schwab Health Care Fund™
  • Fund Family Name Schwab Funds
  • Inception Date Jul 03, 2000
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Jonas Svallin

Fund Description

The Schwab Health Care Fund (SWHFX) is a low-cost, actively managed fund focusing on the health care sector. This includes drug and biotechnology companies, health care facilities operators, medical device manufacturers, medical providers and health insurance firms. The fund’s managers use fundamental analyses to find stocks that have the potential for growth. SWHFX is free to own stocks of any market capitalization as well as international stocks.

Given its single-sector focus, SWHFX is best suited as a satellite position in a broad equity portfolio. The fund is managed by Charles Schwab Investment Management Inc.

SWHFX - Performance

Return Ranking - Trailing

Period SWHFX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 17.2% -14.9% 32.6% 70.54% 4
1 Yr 11.5% -14.8% 47.6% 53.15% 3
3 Yr -0.5% * -7.5% 18.5% 71.30% 4
5 Yr 6.2% * 0.1% 21.9% 78.22% 4
10 Yr 4.5% * -1.3% 14.6% 71.59% 4

* Annualized


Return Ranking - Calendar

Period SWHFX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -6.8% -29.8% 2.6% 15.45% 1
2015 -7.0% -20.4% 14.5% 76.36% 4
2014 7.2% -5.8% 33.7% 80.91% 5
2013 26.4% -2.6% 65.2% 87.16% 5
2012 5.0% -5.3% 36.5% 85.44% 5

Total Return Ranking - Trailing

Period SWHFX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 17.2% -14.9% 32.6% 71.17% 4
1 Yr 11.5% -18.3% 47.6% 54.55% 3
3 Yr 11.0% * -14.2% 18.5% 31.48% 2
5 Yr 30.7% * 0.1% 30.9% 19.80% 1
10 Yr 22.0% * 1.2% 26.2% 14.46% 1

* Annualized


Total Return Ranking - Calendar

Period SWHFX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -6.8% -25.1% 6.3% 17.43% 1
2015 9.6% -16.6% 39.1% 28.44% 2
2014 31.8% -5.8% 100.0% 58.72% 3
2013 83.3% -5.1% 398.7% 37.04% 2
2012 62.9% -2.6% 475.8% 15.00% 1

NAV & Total Return History

SWHFX - Holdings

Filings data as of: Mar 31, 2017

Concentration Analysis

SWHFX Category Low Category High SWHFX % Rank Quintile
Net Assets 839 M 20.4 M 46.9 B 18.75% 4
Number of Holdings 86 32 355 16.07% 3
Net Assets in Top 10 379 M 9.25 M 20.1 B 19.64% 4
Weighting of Top 10 45.4% 19.5% 74.0% 13.39% 2

Top 10 Holdings

  1. Johnson & Johnson 7.60%
  2. Pfizer Inc 6.06%
  3. Gilead Sciences Inc 2.79%
  4. Amgen Inc 5.11%
  5. Celgene Corp 4.34%
  6. Merck & Co Inc 5.85%
  7. Roche Holding AG Dividend Right Cert. 3.57%
  8. UnitedHealth Group Inc 3.81%
  9. GlaxoSmithKline PLC 3.22%
  10. Biogen Inc 3.04%

Asset Allocation

Weighting Category Low Category High SWHFX % Rank Quintile
Stocks
99.48% 88.73% 100.89% 7.14% 1
Other
0.46% -11.71% 2.70% 8.04% 2
Cash
0.07% 0.00% 12.07% 28.57% 4
Preferred Stocks
0.00% 0.00% 0.71% 6.25% 1
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 1
Bonds
0.00% 0.00% 2.91% 4.46% 1

Stock Sector Breakdown

Weighting Category Low Category High SWHFX % Rank Quintile
Healthcare
93.92% 11.52% 99.64% 24.11% 4
Technology
3.25% 0.00% 64.38% 6.25% 1
Basic Materials
1.96% 0.00% 1.96% 0.89% 1
Industrials
0.07% 0.00% 8.05% 8.93% 2
Utilities
0.00% 0.00% 1.11% 1.79% 1
Real Estate
0.00% 0.00% 1.50% 2.68% 1
Financial Services
0.00% 0.00% 5.16% 5.36% 1
Energy
0.00% 0.00% 0.00% 0.89% 1
Communication Services
0.00% 0.00% 0.00% 0.89% 1
Consumer Defense
0.00% 0.00% 2.14% 12.50% 3
Consumer Cyclical
0.00% 0.00% 5.10% 7.14% 2

Stock Geographic Breakdown

Weighting Category Low Category High SWHFX % Rank Quintile
US
75.24% 62.83% 99.64% 30.36% 5
Non US
24.24% 0.00% 37.17% 3.57% 1

SWHFX - Expenses

Operational Fees

SWHFX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.80% 0.10% 4.31% 66.07% 1
Management Fee 0.53% 0.09% 1.25% 16.07% 1
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

SWHFX Fees (% of AUM) Category Low Category High SWHFX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

SWHFX Fees (% of AUM) Category Low Category High SWHFX Rank Quintile
Max Redemption Fee 2.00% 0.75% 2.00% 2.27% 3

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SWHFX Fees (% of AUM) Category Low Category High SWHFX Rank Quintile
Turnover 54.00% 0.00% 699.00% 13.39% 4

SWHFX - Distributions

Dividend Yield Analysis

SWHFX Category Low Category High SWHFX % Rank Quintile
Dividend Yield 0.2% 0.01% 0.94% 17.02% 1

Dividend Distribution Analysis

SWHFX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

SWHFX Category Low Category High SWHFX % Rank Quintile
Net Income Ratio 0.82% -2.22% 1.40% 4.46% 1

Capital Gain Distribution Analysis

SWHFX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

SWHFX - Managers

Jonas Svallin

Manager

Start Date

Aug 03, 2012

Tenure

4.83

Tenure Rank

13.3%

Jonas Svallin, CFA, a managing director and portfolio manager for the Charles Schwab Investment Management, Inc., leads the portfolio management team of Schwab’s disciplined active equity strategies, and is responsible for the day-to-day co-management of the fund. Prior to joining CSIM in 2012, Mr. Svallin spent nearly three years as a partner and a director of quantitative analytics & research at Fiduciary Research & Consulting, where he provided oversight of quantitative analytics and risk management efforts. From 2003 until 2009, Mr. Svallin was a principal and head portfolio manager at Algert Coldiron Investors (ACI). Prior to joining ACI, Mr. Svallin worked as a quantitative research associate at RCM Capital Management and a senior consultant at FactSet Research Systems.


Iain Clayton

Manager

Start Date

Feb 27, 2015

Tenure

2.26

Tenure Rank

18.3%

Iain Clayton, CFA, FRM,Managing Director and Senior Portfolio Manager, is responsible for the day-to-day co-management of the Schwab Core Equity Fund, Schwab International Core Equity Fund and Schwab Health Care Fund. Prior to joining CSIM in 2013, Mr. Clayton spent more than five years at SSI Investment Management, where he was a portfolio manager and director of quantitative research. In these roles, Mr. Clayton co-managed multiple investment strategies and developed quantitative models and valuation approaches. From 2004 to 2008, he worked as a portfolio manager and director at Allianz Global Investors (formerly RCM Capital Management) and helped manage various equity portfolios and developed fundamental-based stock selection models. Prior to that, he was a vice president at Eureka Investment Advisors for almost three years and also served as a senior quantitative analyst/assistant portfolio manager. He has also worked as a quantitative research analyst at Allianz Global Investors.


Wei Li

Manager

Start Date

Jun 14, 2013

Tenure

3.96

Tenure Rank

15.6%

Wei Li, Ph.D., CFA, Portfolio Manager, is responsible for the day-to-day co-management of the fund. Prior to joining CSIM in 2012, Ms. Li spent more than ten years at BlackRock, Inc. (formerly Barclays Global Investors), where she held a number of positions. From 2001 to 2009, she worked in various roles in the Global Advanced Active group, including portfolio management and quantitative research for both U.S. and international equity markets. After 2009, she worked in the defined contribution research and product development area for almost two years.


Tenure Analysis

Category Low

0.3

Category High

19.7

Category Average

9.02

Category Mode

0.3